Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

Nifty's 2027 challenge: Can it outrun S&P 500 amid global mkt uncertainty?

2 weeks ago 17

PROTECT YOURSELF with Orgo-Life® QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

Home / Markets / News / Nifty's 2027 challenge: Can it outrun S&P 500 amid global mkt uncertainty?

India's earnings growth and relatively lower trailing valuations offer hope, but foreign outflows and external risks could limit the Nifty's recovery

NSE

premium

Indian equities face a test as investors weigh earnings growth and valuations against the stronger performance of US stocks.

Pravin Palande Mumbai

4 min read

Last Updated :

Oct 11 2026 | 11:08 PM

IST

Wall Street is scaling record highs, while Dalal Street struggles to regain lost ground. The Nifty 50 has fallen 11 per cent over the past year, compared with a 17 per cent return for the S&P 500, raising the question of whether Indian equities can turn the tables next year. 

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway